Brean Capital Initiates Globus Medical At Buy

Analysts at Brean Capital initiated coverage on shares of Globus Medical

with a Buy rating. The target price for Globus Medical is set to $28. Globus Medical shares have gained 15.02% over the past 52 weeks, while the S&P 500 index has surged 15.31% in the same period. Globus Medical shares rose 2.32% to $22.02 in pre-market trading.